Cargando…

Pathogenesis and treatment of osteoporosis in patients with hemophilia

INTRODUCTION: Hemophilia is a rare X-linked recessive inherited bleeding disorder caused by mutations of the genes encoding coagulation factor VIII (FVIII) or IX (FIX). Patients with hemophilia (PWH) often have a high risk of osteoporosis and fractures that is usually ignored. Herein, we review the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xiaoyun, Gao, Peng, Zhang, Qian, Jiang, Yan, Wang, Ou, Xia, Weibo, Li, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813251/ https://www.ncbi.nlm.nih.gov/pubmed/36598583 http://dx.doi.org/10.1007/s11657-022-01203-9

Ejemplares similares

Genotypic and Phenotypic Spectrum and Pathogenesis of WNT1 Variants in a Large Cohort of Patients With OI/Osteoporosis
por: Hu, Jing, et al.
Publicado: (2023)

Osteoporosis pathogenesis and treatment: existing and emerging avenues
por: Liang, Bo, et al.
Publicado: (2022)

Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review
por: Liao, Ruo-xi, et al.
Publicado: (2014)

Hemophilia B: molecular pathogenesis and mutation analysis
por: Goodeve, A. C.
Publicado: (2015)

The Role of Macrophage in the Pathogenesis of Osteoporosis
por: Yang, Deng-Ho, et al.
Publicado: (2019)

Skeletal outcomes of patients with osteogenesis imperfecta during drug holiday of bisphosphonates: a real-world study
por: Zhang, Yongze, et al.
Publicado: (2022)

Treatment adherence in hemophilia
por: Thornburg, Courtney D, et al.
Publicado: (2017)

Bone Microarchitecture in Obese Postmenopausal Chinese Women: The Chinese Vertebral Osteoporosis Study (ChiVOS)
por: Qi, Wenting, et al.
Publicado: (2022)

Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study
por: Li, Nan, et al.
Publicado: (2018)

Health-related quality of life of men with primary osteoporosis and its changes after bisphosphonates treatment
por: Zhao, Di-chen, et al.
Publicado: (2023)

Aspects of prophylactic treatment of hemophilia
por: Ljung, Rolf
Publicado: (2016)

Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors
por: Saba, Hussain I, et al.
Publicado: (2011)

Insights into the Role of Macrophage Polarization in the Pathogenesis of Osteoporosis
por: Wang, Wenhao, et al.
Publicado: (2022)

Osteoporosis in Patients With Hemophilia: Single-Center Results From a Middle-Income Country
por: Sahin, Serdar, et al.
Publicado: (2019)

Overview of the clinical efficacy and safety of eldecalcitol for the treatment of osteoporosis
por: Cui, Lijia, et al.
Publicado: (2022)

Modulation of the vitamin D/vitamin D receptor system in osteoporosis pathogenesis: insights and therapeutic approaches
por: Li, Yanqi, et al.
Publicado: (2023)

New Function of Cholesterol Oxidation Products Involved in Osteoporosis Pathogenesis
por: Che, Yanting, et al.
Publicado: (2022)

Treatment of Hemophilia
Publicado: (1896)

Role of Exosomal MicroRNAs and Their Crosstalk with Oxidative Stress in the Pathogenesis of Osteoporosis
por: Lu, Jun, et al.
Publicado: (2021)

The management of hemophilia in elderly patients
por: Franchini, Massimo, et al.
Publicado: (2007)

THE PATHOGENESIS OF HEMOPHILIA : AN EXPERIMENTAL ANALYSIS OF THE ANTICEPHALIN HYPOTHESIS IN HEMOPHILIC DOGS
por: Graham, John B., et al.
Publicado: (1957)

RNAi for the Treatment of People with Hemophilia: Current Evidence and Patient Selection
por: Boyce, Sara, et al.
Publicado: (2023)

Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment
por: Rotta, Denise, et al.
Publicado: (2020)

Advanced therapies for the treatment of hemophilia: future perspectives
por: Liras, Antonio, et al.
Publicado: (2012)

Hemophilia A in Brazil – epidemiology and treatment developments
por: Ferreira, Adriana Aparecida, et al.
Publicado: (2014)

Barriers and perceived limitations to early treatment of hemophilia
por: Saxena, Kapil
Publicado: (2013)

Acquired hemophilia A: emerging treatment options
por: Janbain, Maissaa, et al.
Publicado: (2015)

Recent Advances in the Treatment of Hemophilia: A Review
por: Marchesini, Emanuela, et al.
Publicado: (2021)

Gene Therapy Approaches for the Treatment of Hemophilia B
por: Soroka, Anastasiia B., et al.
Publicado: (2023)

Osteoporosis Complications in Crohn's Disease Patients: Factors, Pathogenesis, and Treatment Outlines
por: Baban, Yaqot N, et al.
Publicado: (2021)

Therapeutic Effects of Kefir Peptides on Hemophilia-Induced Osteoporosis in Mice With Deficient Coagulation Factor VIII
por: Yen, Chih-Ching, et al.
Publicado: (2022)

How genomics has informed our understanding of the pathogenesis of osteoporosis
por: Johnson, Mark L, et al.
Publicado: (2009)

The Molecular Basis of FIX Deficiency in Hemophilia B
por: Shen, Guomin, et al.
Publicado: (2022)

Comorbidities of cardiovascular disease and cancer in hemophilia patients
por: Wang, Jiaan-Der
Publicado: (2016)

Molecular Diagnosis of Hemophilia A and Pathogenesis of Novel F8 Variants in Shanxi, China
por: Zhang, Xialin, et al.
Publicado: (2023)

The Asian Federation of Osteoporosis Societies' call to action to improve the undertreatment of osteoporosis in Asia
por: Yeap, Swan Sim, et al.
Publicado: (2017)

Atypical skeletal manifestations of rickets in a familial hypocalciuric hypercalcemia patient
por: Wu, Bo, et al.
Publicado: (2017)

Costs and utilization of treatment in patients with hemophilia
por: Rocha, Patrícia, et al.
Publicado: (2015)

Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management
por: Lan, Gong-bin, et al.
Publicado: (2015)

Treatment of hemophilia B: focus on recombinant factor IX
por: Franchini, Massimo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pk04mabuqj2h9j09tf78jol4di